|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/22 | |
| A61K 39/395 | |||
| A61P 43/00 | |||
| A61K 39/00 |
| (11) | Patento numeris | 2797953 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12805890.6 |
| Europos patento paraiškos padavimo data | 2012-12-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-11-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/068975 |
| Data | 2012-12-11 |
| (87) | Numeris | WO 2013/101451 |
| Data | 2013-07-04 |
| (30) | Numeris | Data | Šalis |
| 201161580964 P | 2011-12-28 | US |
| (72) |
KE, Hua, Zhu, US
LIU, Min, US
GIANNOBILE, William, V., US
|
| (73) |
The Regents of the University of Michigan,
1600 Huron Parkway, 2nd Floor, Ann Arbor, MI 48109-2590,
US
Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US |
| (54) | METHOD OF TREATING ALVEOLAR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES |
| METHOD OF TREATING ALVEOLAR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES |